Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAMUEL H FRIEDMAN

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1356363352
CMS profile
60749
Location
HACKENSACK, NJ

General Payments · PY2018–2024

$2,737.17

  • Reported across 197 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$243.15

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $243.15 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $176.64 11
Boehringer Ingelheim Pharmaceuticals, Inc. $66.51 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $87.36 7
PY2019 $833.91 73
PY2020 $613.41 38
PY2021 $326.56 24
PY2022 $287.17 19
PY2023 $345.61 21
PY2024 $243.15 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim Pharmaceuticals, Inc. $14.13 02/01/2024 Food and Beverage Undisputed 01/23/2026 1117976610 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.26 02/21/2024 Food and Beverage Undisputed 01/23/2026 1117976614 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.53 03/26/2024 Food and Beverage Undisputed 01/23/2026 1117976616 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.59 04/16/2024 Food and Beverage Undisputed 01/23/2026 1117976612 CMS
Novo Nordisk Inc $18.29 01/09/2024 Food and Beverage Undisputed 01/23/2026 1097628604 CMS
Novo Nordisk Inc $16.25 02/08/2024 Food and Beverage Undisputed 01/23/2026 1097472830 CMS
Novo Nordisk Inc $19.18 02/27/2024 Food and Beverage Undisputed 01/23/2026 1096806192 CMS
Novo Nordisk Inc $16.25 03/20/2024 Food and Beverage Undisputed 01/23/2026 1097690301 CMS
Novo Nordisk Inc $13.77 06/04/2024 Food and Beverage Undisputed 01/23/2026 1096881139 CMS
Novo Nordisk Inc $16.16 07/09/2024 Food and Beverage Undisputed 01/23/2026 1096862286 CMS
Novo Nordisk Inc $16.25 07/23/2024 Food and Beverage Undisputed 01/23/2026 1096737512 CMS
Novo Nordisk Inc $11.93 08/14/2024 Food and Beverage Undisputed 01/23/2026 1097459234 CMS
Novo Nordisk Inc $15.15 09/23/2024 Food and Beverage Undisputed 01/23/2026 1097777935 CMS
Novo Nordisk Inc $17.91 11/06/2024 Food and Beverage Undisputed 01/23/2026 1097606334 CMS
Novo Nordisk Inc $15.50 12/17/2024 Food and Beverage Undisputed 01/23/2026 1097428347 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.